Losses Persist, Yet Huntsman Raises Prices — A Quiet Turning Point in the MDI Cycle
When Huntsman reported a full-year net loss of $284 million for 2025, the market reaction was not panic, but something more nuanced. The numbers were undeniably weak, yet the real significance lay not in the loss itself, but in how it emerged—and in how the company responded while still operating in negative territory.
In the fourth quarter, Huntsman recorded revenue of $1.355 billion, down 6.7% year over year, with a net loss of $96 million. For the full year, revenue reached $5.683 billion, declining 5.8%. These figures reflect a familiar pattern across the chemical sector over the past two years: demand recovery has been uneven, pricing pressure persistent, and margins compressed across product chains. At the same time, however, Huntsman generated $298 million in operating cash flow from continuing operations and $125 million in free cash flow, representing a 23.8% increase from the prior year. This divergence between accounting losses and strengthening cash generation suggests that operational discipline remains intact.
The most significant pressure was concentrated in the Polyurethanes segment, Huntsman’s core business. Full-year revenue in this division reached $3.697 billion, down 5%, while adjusted EBITDA declined by 40%. Importantly, this deterioration was driven not by collapsing volumes but by falling prices. Average MDI selling prices declined 11%, even as volumes increased 2%. This dynamic highlights the fundamental challenge facing the market: demand has not disappeared, but excess supply continues to suppress profitability across the value chain.
As a critical feedstock in polyurethane production, MDI directly influences multiple end-use sectors, including building insulation, automotive interiors, appliance insulation systems, and industrial elastomers. Over the past several years, global MDI capacity expansions—particularly in Asia—have contributed to structurally looser supply conditions. As new production facilities came online, pricing pressure intensified, and even incremental demand recovery proved insufficient to restore margins.
Against this backdrop, Huntsman made a decision that might appear counterintuitive at first glance. The company implemented a price increase of €350 per metric ton for MDI across Europe, the Middle East, and Africa, followed shortly by a $260 per metric ton increase in the United States, alongside adjustments for polyether products.
Viewed narrowly through a short-term demand lens, such actions might seem difficult to justify. However, from a cyclical perspective, the logic becomes clearer.
Chemical pricing dynamics are rarely driven by demand alone. Instead, they reflect the interaction between supply constraints, cost structures, and producer behavior. During downturns, companies often prioritize maintaining operating rates and market share through price concessions. Yet this strategy has limits. Once prices approach cash cost levels, further reductions threaten long-term sustainability. At that point, producers begin to reassert pricing discipline, not necessarily in response to immediate demand recovery, but to prevent structural margin erosion.
Huntsman’s current pricing actions suggest that the industry has entered precisely this phase.
Equally notable is the company’s emphasis on financial discipline. Huntsman has consistently highlighted cash flow preservation, balance sheet strength, and cost control as strategic priorities. This focus indicates a shift away from volume-driven growth toward resilience and long-term positioning.
In cyclical industries, profitability often lags behind operational recovery. Cash flow stability, by contrast, provides a more reliable signal of structural health. Companies that maintain liquidity and cost discipline during downturns are better positioned to capture upside when market conditions improve.
The structure of the global MDI market reinforces this outlook. With a relatively concentrated supplier base, long-term pricing cannot remain disconnected from production economics indefinitely. As capacity growth moderates and demand gradually stabilizes, pricing equilibrium becomes more achievable.
Huntsman’s recent price increases should therefore be interpreted less as an attempt to immediately boost earnings and more as an effort to re-establish pricing boundaries. Once downward momentum in prices slows, market expectations begin to shift. Customers move from deferring purchases to securing supply, and margin recovery can follow.
Such transitions rarely appear first in financial statements. They emerge initially through producer behavior.
From this perspective, Huntsman’s losses and its pricing actions are not contradictory. They represent two stages of the same cycle. The losses reflect past oversupply conditions, while the price increases signal a strategic repositioning for future recovery.
In the chemical industry, cycles do not end when losses disappear. They end when producers regain the confidence to defend price.
Huntsman’s actions suggest that moment may already be approaching.
2026-10-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
INEOS Closes US Polystrene Plant: 400K Tons of PD in the US Can't Hold On
-
Lotte Merges with HD Hyundai: Can Korea’s Petrochemical First Case Trigger True Restructuring?
-
Evonik Cuts 3,200 Jobs: Europe’s Chemical Winter Is Not Over
-
As Middle East Supply Faces Disruptions, SABIC's 1.8 Million Mt/Year Methanol New Project Secures Saudi Feedstock Quota
-
South Korea Moves Urgently to Control Petrochemical Feedstock Hoarding as Supply Chain Risk Escalates to the National Security Level
-
Dow Swings from an $801 Million Loss to an $802 Million Profit as Hormuz Disruption Lifts Polyethylene Prices
-
Türkiye Advances $3 Billion Petrochemical Cluster Targeting 17% of Domestic Polypropylene Demand
-
Argentina to Build Latin America’s Largest Urea Plant Under €1.3 Billion Contract
-
Hormuz Crisis Pushes Up Urea Prices as Yara’s Quarterly EBITDA Jumps 39%
-
AstraZeneca Pays Up to $1.5 Billion for Global Rights to Chinese Lung Cancer Drug
Recommend Reading
-
AkzoNobel Invests €50 Million to Expand Aerospace Coatings Operations in the United States
-
Sanofi’s $2.2 Billion Dynavax Acquisition: Why Big Pharma Is Rebuilding the Global Vaccine Order
-
“The Agency Revolution”: BASF Breaks Into Dongfeng Liuzhou’s Supply Chain
-
Lilly Bets US$3 Billion on China While Simultaneously Cracking Down on the Gray Market for Weight-Loss Drugs
-
Ibuprofen API Giant to Expand Capacity by 50%, Annual Capacity to Reach 18,000 Tonnes
-
On January 30, the price of pure benzene in China increased
-
Remote Cost Fluctuations September ABS Prices Show Increases
-
Applications of Caesium Iodide
-
Business Society PVC Trend Analysis for September 30, 2026: Slightly Bullish with Volatility
-
Business Society September 22, 2026 Palm Oil Trend Analysis: Volatility